company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6687000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6687000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,433000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1350000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2367000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7271000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7271000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-328000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-328000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-328000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7661000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7670000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7670000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q1,2012-01-01,2012-03-31,2013-06-05 13:01:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,71000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6368000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6368000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,411000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1354000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-35000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4638000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4638000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-119000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-119000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-119000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5643000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5643000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5643000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,886000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4250000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4250000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,375000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1286000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3058000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,469000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,469000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-310000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-310000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-310000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,191000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,191000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,191000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,350000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7073000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7073000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,443000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4688000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-245000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2187000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2187000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-263000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-263000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-263000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1350000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1493000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1493000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-957000.0
INSYS Therapeutics Inc,INSY,,0001516479,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,98000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,429000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1697000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1339000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,930000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,930000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-105000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-105000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-105000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-500000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-500000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-500000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,325000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 19:38:30+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4547000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4547000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,436000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1607000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4534000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2056000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2056000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2125000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2125000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2125000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11358000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,32456000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,31000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21129000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21129000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21060000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11587000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11587000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,446000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1697000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2876000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10854000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10854000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-557000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-800000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1357000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1357000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,103000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,103000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,103000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9600000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,24100000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24100000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,477000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-507000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13661000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10409000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10409000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2338000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,400000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1938000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1938000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,852000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4713000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5565000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5565000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14036000.0
INSYS Therapeutics Inc,INSY,,0001516479,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,991000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7658000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7658000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,523000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2726000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1309000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6764000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6764000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3015000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16846000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19861000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19861000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7725000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7725000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7725000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5372000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 15:57:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9465000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9465000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,584000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1486000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5858000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14421000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14421000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5399000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12318000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,400000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17317000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17317000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1108000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7917000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9025000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9025000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6129000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2199000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11505000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11505000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,604000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4053000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4540000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12596000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12596000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7273000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12956000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20229000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20229000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8904000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8904000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8904000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1271000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-9000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7426000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7426000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,789000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,367000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2105000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6117000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16804000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16804000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6558000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14485000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8195000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12848000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12848000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,881000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5859000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6740000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6740000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10696000.0
INSYS Therapeutics Inc,INSY,,0001516479,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,785000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5867000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5867000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1175000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,194000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8160000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1456000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16852000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16852000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5191000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10469000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4045000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11615000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11615000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6731000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6731000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6731000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11968000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q1,2015-01-01,2015-03-31,2017-04-07 17:20:04+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9413000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9413000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1282000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,285000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2629000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2115000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15724000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15724000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2915000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36881000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19763000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20033000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20033000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1479000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6791000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8270000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8270000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3961000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3350000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,24631000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24631000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1368000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,379000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2085000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14000000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,42463000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,42463000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2637000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36686000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14108000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25215000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25215000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2697000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2697000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2697000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19945000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3005000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18142000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18142000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1466000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,573000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4540000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2518000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,27239000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,27239000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3099000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54434000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24219000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33314000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33314000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-16459000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1168000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6901000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8390000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8390000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14465000.0
INSYS Therapeutics Inc,INSY,,0001516479,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8996000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2290000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2290000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1527000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,569000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3473000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4316000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12175000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12175000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2623000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22574000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18715000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6482000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6482000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-13351000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1963000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11388000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11388000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 14:27:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5695000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6027000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6027000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1496000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,554000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5303000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17300000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3920000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3920000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1878000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19658000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21005000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-531000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-531000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2749000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1576000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1094000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-79000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-79000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4530000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6624000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2925000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2925000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1511000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,469000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11264000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9678000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25847000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25847000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2848000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43250000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43397000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2701000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2701000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1093000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1093000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1093000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24239000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2630000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3652000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3652000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1715000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,437000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8497000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17805000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,24802000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,24802000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3265000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29893000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20840000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12318000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12318000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,1000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,704000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2076000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1371000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1371000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11113000.0
INSYS Therapeutics Inc,INSY,,0001516479,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1488000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1774000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,347000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2697000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14963000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16669000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16669000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1909000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46510000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28165000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20254000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20254000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,654000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,654000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,654000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-36269000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:03:12+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8184000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8184000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1914000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,329000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9592000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14229000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10578000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10578000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7104000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25550000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22176000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10478000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10478000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,836000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1677000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2513000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2513000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18543000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1779000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-166200000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-166200000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1817000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,266000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,136023000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5957000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22137000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22137000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4585000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36443000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47913000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6885000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6885000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1177000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1177000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1177000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14075000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,124000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45927000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45927000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1832000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,183000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1709000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,34343000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11278000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11278000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3063000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23565000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32665000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6037000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6037000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,490000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,995000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1485000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1485000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3756000.0
INSYS Therapeutics Inc,INSY,,0001516479,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,193000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20370000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20370000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1938000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,93000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,795000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,141000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17403000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17403000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-760000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25394000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29583000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3429000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3429000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,524000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13450000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:39:42+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,43000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27350000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27350000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1813000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,21000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8569000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5705000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22652000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22658000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1130000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10495000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30696000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19071000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19071000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,736000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,392000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1128000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1128000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2459000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-50000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30494000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30494000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1938000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-7000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4606000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,24542000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8627000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8621000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2084000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14699000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30043000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13260000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13260000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,116000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,116000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,116000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4755000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46293000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46293000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1890000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-81000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19726000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17451000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7307000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7307000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2121000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11138000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30897000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17638000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17638000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,312000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,64000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,376000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,376000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10707000.0
INSYS Therapeutics Inc,INSY,,0001516479,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-13385000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-123844000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-123844000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1961000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-58000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,80963000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,24319000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16659000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16659000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6005000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27622000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21602000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21602000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,18000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,18000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,18000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4961000.0
INSYS Therapeutics Inc,INSY,,0001516479,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 17:39:42+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-66000.0
